Published • loading... • Updated
Teva Pharm to grow more in 2027 despite US’ IRA impact on Austedo
Summary by WTVB
2 Articles
2 Articles
Teva Pharm to grow more in 2027 despite US’ IRA impact on Austedo - Regional Media News
JERUSALEM, Nov 3 (Reuters) - Teva Pharmaceutical Industries expects to grow in 2027 despite the US inflation reduction act that will cap prices for its top branded drug Austedo to treat Huntington's Disease and Tardive Dyskinesia, CEO Richard Francis said on Tuesday. Francis, in an [...]
Teva Pharm to grow more in 2027 despite US’ IRA impact on Austedo
JERUSALEM, Nov 3 (Reuters) - Teva Pharmaceutical Industries expects to grow in 2027 despite the US inflation reduction act that will cap prices for its top branded drug Austedo to treat Huntington's Disease and Tardive Dyskinesia, CEO Richard Fra...
Coverage Details
Total News Sources2
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
